STOCK TITAN

Apollomics (APLM) director discloses 2,000 RSUs and vesting schedule

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Apollomics Inc. director Jan Chen-Huan reported initial beneficial ownership of 2,000 Restricted Stock Units (RSUs), each tied to one Class A Ordinary Share. The RSUs vested with respect to 500 shares on February 9, 2026, with additional 500-share tranches scheduled on March 15, 2026, June 15, 2026 and September 15, 2026. Each RSU represents a contingent right to receive one Class A Ordinary Share, and the position is held directly.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Jan Chen-Huan

(Last)(First)(Middle)
989 E HILLSDALE BLVD, SUITE 220

(Street)
FOSTER CITY94404

(City)(State)(Zip)


(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (1) (1)Class A Ordinary Shares2,000(2)D
Explanation of Responses:
1. The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026.
2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.
Remarks:
This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.
/s/ Jan, Chen-Huan Jack03/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider position did Jan Chen-Huan report in Apollomics (APLM) Form 3?

Jan Chen-Huan reported holding 2,000 Restricted Stock Units (RSUs) tied to Apollomics Class A Ordinary Shares. This Form 3 is an initial ownership statement, disclosing a starting equity position rather than a new market trade.

How do the 2,000 Apollomics (APLM) RSUs for Jan Chen-Huan vest?

The RSUs vested with respect to 500 shares on February 9, 2026. Additional tranches of 500 shares each are scheduled to vest on March 15, 2026, June 15, 2026 and September 15, 2026, subject to the award terms.

What does each Apollomics (APLM) restricted stock unit represent for Jan Chen-Huan?

Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share of Apollomics. This means the RSUs convert into common equity as they vest, aligning the director’s compensation with future share performance.

Is Apollomics (APLM) director Jan Chen-Huan buying or selling shares in this Form 3?

This Form 3 does not show a buy or sell transaction. It reports an initial holding of 2,000 RSUs, with a defined vesting schedule, rather than an open-market purchase or sale of Apollomics shares.

How is Jan Chen-Huan’s Apollomics (APLM) RSU ownership classified?

The 2,000 Apollomics RSUs are reported as direct ownership. This indicates the director holds the award personally, rather than through a separate trust, partnership, or other indirect investment entity.
APOLLOMICS INC

NASDAQ:APLM

View APLM Stock Overview

APLM Rankings

APLM Latest News

APLM Latest SEC Filings

APLM Stock Data

41.01M
981.33k
Biotechnology
Healthcare
Link
United States
Foster City